Skip to main content
Top
Published in: Endocrine 3/2014

01-08-2014 | Erratum

Erratum to: Biochemical persistence in thyroid cancer: is there anything to worry about?

Authors: Fabián Pitoia, Erika Abelleira, Hernán Tala, Fernanda Bueno, Carolina Urciuoli, Graciela Cross

Published in: Endocrine | Issue 3/2014

Login to get access

Excerpt

The article originally published with the author names reversed. They appear correctly here. …
Metadata
Title
Erratum to: Biochemical persistence in thyroid cancer: is there anything to worry about?
Authors
Fabián Pitoia
Erika Abelleira
Hernán Tala
Fernanda Bueno
Carolina Urciuoli
Graciela Cross
Publication date
01-08-2014
Publisher
Springer US
Published in
Endocrine / Issue 3/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0208-z

Other articles of this Issue 3/2014

Endocrine 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine